- acute myeloid leukemia (AML)
- myelodysplastic syndromes (MDS)
SY-1425 is a selective retinoic acid receptor alpha (RARα) agonist for genomically defined subsets of patients whose disease is characterized by the overexpression of the RARA gene. SY-1425 is in clinical trials for RARA-positive patients.